Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients.
Serum liver enzymes are frequently tested in clinics to aid disease diagnosis. Large observational studies indicated that these enzymes might predict cancer risk and mortality. However, no prospective study has reported on their relationships with the risk of HBV-related hepatocellular carcinoma (HC...
Main Authors: | Hie-Won Hann, Shaogui Wan, Ronald E Myers, Richard S Hann, Jinliang Xing, Bicui Chen, Hushan Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3480412?pdf=render |
Similar Items
-
Update Treatment for HBV Infection and Persistent Risk for Hepatocellular Carcinoma: Prospect for an HBV Cure
by: Joseph Yoo, et al.
Published: (2018-04-01) -
Polymorphisms in Genes of Tricarboxylic Acid Cycle Key Enzymes Are Associated with Early Recurrence of Hepatocellular Carcinoma.
by: Shaogui Wan, et al.
Published: (2015-01-01) -
Comprehensive investigation of HBV-related hepatocellular carcinoma and choice of anti-HBV therapy
by: Huihui Lu, et al.
Published: (2021-08-01) -
Gender Disparity in Host Responses to Hepatitis B-Related Hepatocellular Carcinoma: A Case Series
by: Rukaiya Bashir Hamidu, et al.
Published: (2021-07-01) -
Serum/Plasma MicroRNAs as Biomarkers for HBV-Related Hepatocellular Carcinoma in China
by: Wen Yin, et al.
Published: (2015-01-01)